Toll Free : + 1-888-961-4454 | Int'l : + 91 (788) 802-9103 | support@researchdive.com
LI2010736 |
Pages: 310 |
Sep 2024 |
The cannula market was valued at $172.90 million in 2023 and is estimated to reach $ 318.77 million by 2033, exhibiting a CAGR of 6.7% from 2024 to 2033.
A cannula is a thin tube inserted into a vein or body cavity to administer medication, drain fluid, or insert a surgical instrument. The word "cannula" comes from the Latin word "canna," meaning "reed" or "tube," reflecting its shape and function. Cannulas are widely used in medical procedures. For instance, in intravenous therapy, a cannula is used to provide a passage for fluid infusions, medications, or to draw blood. They come in various sizes and types depending on their specific application, such as nasal cannulas for oxygen delivery or intravenous cannulas for fluid administration.
The design of a cannula typically includes a hollow, flexible tube that allows for the passage of fluids or instruments, making it an essential tool in both medical and surgical settings.
Greater awareness and more extensive screening programs for various diseases have increased the diagnosis rates, thereby increasing the number of patients requiring medical interventions that involve the use of cannulas. The trend towards minimally invasive surgical techniques, which often require specialized cannulas, is another significant market driver. These techniques offer benefits such as reduced recovery time and lower risk of complications, making them popular choices in modern medical practice. The expansion of home healthcare services has also fueled the demand for cannulas. Many patients who require regular medical treatments prefer home care, necessitating the availability of cannulas for routine medication administration and other therapies at home. Thes factors are anticipated to drive the market growth.
The presence of alternative methods for drug delivery and fluid management, such as oral medications, patches, or less invasive devices, can limit the demand for cannulas. Healthcare providers might opt for these alternatives due to ease of use, lower cost, or patient preference. In many parts of the world, economic constraints limit healthcare spending. This can affect the procurement of medical devices, including cannulas, particularly in public healthcare settings or low-income regions. These factors are anticipated to restrain the market growth.
Beyond traditional uses, the expanding applications of cannulas in emerging fields such as regenerative medicine, stem cell therapy, and aesthetic procedures (like liposuction) offer new growth avenues. The versatility of cannulas makes them suitable for various medical and cosmetic procedures, broadening their market potential. Advances in cannula design and materials offer significant opportunities. Development of more flexible, biocompatible, and minimally invasive cannulas can enhance patient comfort and safety, driving higher adoption rates. Innovations like antimicrobial-coated cannulas can reduce infection risks and attract more users. These factors are anticipated to drive the market opportunity.
The cannula market is a segment within the larger medical devices industry, specifically focusing on devices used for various medical purposes such as drug delivery, fluid infusion, and surgical procedures. Cannulas are thin tubes inserted into the body for these purposes, often used in conjunction with needles or other medical instruments.
The medical devices market is influenced by factors such as technological advancements, healthcare infrastructure development, regulatory policies, and demographics. As healthcare needs evolve and populations age, there's a growing demand for innovative medical devices, including cannulas, to improve patient care and outcomes.
The cannula market is segmented into product, application, end user, and region. On the basis of product, the market is divided into nasal cannula, vascular cannula, venous cannula, cardiac cannula, arthroscopy cannula, intravenous cannula, dermatology cannula, and others. As per application, the market is segregated into orthopedics surgery, general surgery, cardiovascular surgery, plastic surgery, oxygen therapy, and others. On the basis of end user, the market is segmented into hospitals, clinics, ambulatory surgery centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The cannula market in the Asia-Pacific region is projected to show the fastest growth during the forecast period. The aging population in Asia-Pacific is contributing to the expansion of the healthcare sector. Elderly individuals often require medical interventions and surgeries, which boosts the demand for cannulas for various treatments and procedures. The region is experiencing a rise in chronic diseases like cardiovascular diseases, diabetes, and respiratory disorders. Cannulas are essential components in the treatment and management of these conditions.
Government initiatives aimed at improving healthcare infrastructure, enhancing access to healthcare services, and promoting medical device manufacturing are supporting the growth of the cannula market in the Asia-Pacific region.
Efforts to address challenges in the pharmaceutical industry within the Asia-Pacific region include collaborative regulatory initiatives. Countries are working together to meet both domestic and global needs for medical products.
The major players operating in the cannula market include Medtronic, Becton Dickinson (BD), Edward Lifesciences, LivaNova, Smiths Medical, Boston Scientific Corporation, Terumo Corporation, Fisher & Paykel Healthcare Ltd, Flexicare Medical, and Medin Medical Innovations.
The cannula market is witnessing significant growth and expansion globally, driven by increasing healthcare expenditure, growing prevalence of chronic diseases, and rising demand for minimally invasive surgical procedures in emerging economies. Manufacturers are expanding their presence in untapped markets, establishing strategic partnerships, and investing in research and development to capitalize on new opportunities and address unmet medical needs.
Aspect | Particulars |
Historical Market Estimations | 2021-2022 |
Base Year for Market Estimation | 2023 |
Forecast Timeline for Market Projection | 2024-2033 |
Geographical Scope | North America, Europe, Asia-Pacific, and LAMEA |
Segmentation by Product |
|
Segmentation by Application |
|
Segmentation by End User |
|
Key Companies Profiled |
|
1. Research Methodology
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
2. Report Scope
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on global Cannula Market
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Legal
4.6.6. Environmental
4.7. Impact of COVID-19 on Cannula Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
5. Cannula Market Analysis, by Product
5.1. Overview
5.2. Nasal Cannula
5.2.1. Definition, key trends, growth factors, and opportunities
5.2.2. Market size analysis, by region, 2023-2033
5.2.3. Market share analysis, by country, 2023-2033
5.3. Vascular Cannula
5.3.1. Definition, key trends, growth factors, and opportunities
5.3.2. Market size analysis, by region, 2023-2033
5.3.3. Market share analysis, by country, 2023-2033
5.4. Venous Cannula
5.4.1. Definition, key trends, growth factors, and opportunities
5.4.2. Market size analysis, by region, 2023-2033
5.4.3. Market share analysis, by country, 2023-2033
5.5. Cardiac Cannula
5.5.1. Definition, key trends, growth factors, and opportunities
5.5.2. Market size analysis, by region, 2023-2033
5.5.3. Market share analysis, by country, 2023-2033
5.6. Arthroscopy Cannula
5.6.1. Definition, key trends, growth factors, and opportunities
5.6.2. Market size analysis, by region, 2023-2033
5.6.3. Market share analysis, by country, 2023-2033
5.7. Intravenous Cannula
5.7.1. Definition, key trends, growth factors, and opportunities
5.7.2. Market size analysis, by region, 2023-2033
5.7.3. Market share analysis, by country, 2023-2033
5.8. Dermatology Cannula
5.8.1. Definition, key trends, growth factors, and opportunities
5.8.2. Market size analysis, by region, 2023-2033
5.8.3. Market share analysis, by country, 2023-2033
5.9. Others
5.9.1. Definition, key trends, growth factors, and opportunities
5.9.2. Market size analysis, by region, 2023-2033
5.9.3. Market share analysis, by country, 2023-2033
5.10. Research Dive Exclusive Insights
5.10.1. Market attractiveness
5.10.2. Competition heatmap
6. Cannula Market Analysis, by Application
6.1. Orthopedics Surgery
6.1.1. Definition, key trends, growth factors, and opportunities
6.1.2. Market size analysis, by region, 2023-2033
6.1.3. Market share analysis, by country, 2023-2033
6.2. General Surgery
6.2.1. Definition, key trends, growth factors, and opportunities
6.2.2. Market size analysis, by region, 2023-2033
6.2.3. Market share analysis, by country, 2023-2033
6.3. Cardiovascular Surgery
6.3.1. Definition, key trends, growth factors, and opportunities
6.3.2. Market size analysis, by region, 2023-2033
6.3.3. Market share analysis, by country, 2023-2033
6.4. Plastic Surgery
6.4.1. Definition, key trends, growth factors, and opportunities
6.4.2. Market size analysis, by region, 2023-2033
6.4.3. Market share analysis, by country, 2023-2033
6.5. Oxygen Therapy
6.5.1. Definition, key trends, growth factors, and opportunities
6.5.2. Market size analysis, by region, 2023-2033
6.5.3. Market share analysis, by country, 2023-2033
6.6. Others
6.6.1. Definition, key trends, growth factors, and opportunities
6.6.2. Market size analysis, by region, 2023-2033
6.6.3. Market share analysis, by country, 2023-2033
6.7. Research Dive Exclusive Insights
6.7.1. Market attractiveness
6.7.2. Competition heatmap
7. Cannula Market Analysis, by End User
7.1. Hospitals
7.1.1. Definition, key trends, growth factors, and opportunities
7.1.2. Market size analysis, by region, 2023-2033
7.1.3. Market share analysis, by country, 2023-2033
7.2. Clinics
7.2.1. Definition, key trends, growth factors, and opportunities
7.2.2. Market size analysis, by region, 2023-2033
7.2.3. Market share analysis, by country, 2023-2033
7.3. Ambulatory Surgery Centers
7.3.1. Definition, key trends, growth factors, and opportunities
7.3.2. Market size analysis, by region, 2023-2033
7.3.3. Market share analysis, by country, 2023-2033
7.4. Others
7.4.1. Definition, key trends, growth factors, and opportunities
7.4.2. Market size analysis, by region, 2023-2033
7.4.3. Market share analysis, by country, 2023-2033
7.5. Research Dive Exclusive Insights
7.5.1. Market attractiveness
7.5.2. Competition heatmap
8. Cannula Market, by Region
8.1. North America
8.1.1. U.S.
8.1.1.1. Market size analysis, by Product, 2023-2033
8.1.1.2. Market size analysis, by Application, 2023-2033
8.1.1.3. Market size analysis, by End User, 2023-2033
8.1.2. Canada
8.1.2.1. Market size analysis, by Product, 2023-2033
8.1.2.2. Market size analysis, by Application, 2023-2033
8.1.2.3. Market size analysis, by End User, 2023-2033
8.1.3. Mexico
8.1.3.1. Market size analysis, by Product, 2023-2033
8.1.3.2. Market size analysis, by Application, 2023-2033
8.1.3.3. Market size analysis, by End User, 2023-2033
8.1.4. Research Dive Exclusive Insights
8.1.4.1. Market attractiveness
8.1.4.2. Competition heatmap
8.2. Europe
8.2.1. Germany
8.2.1.1. Market size analysis, by Product, 2023-2033
8.2.1.2. Market size analysis, by Application, 2023-2033
8.2.1.3. Market size analysis, by End User, 2023-2033
8.2.2. UK
8.2.2.1. Market size analysis, by Product, 2023-2033
8.2.2.2. Market size analysis, by Application, 2023-2033
8.2.2.3. Market size analysis, by End User, 2023-2033
8.2.3. France
8.2.3.1. Market size analysis, by Product, 2023-2033
8.2.3.2. Market size analysis, by Application, 2023-2033
8.2.3.3. Market size analysis, by End User, 2023-2033
8.2.4. Spain
8.2.4.1. Market size analysis, by Product, 2023-2033
8.2.4.2. Market size analysis, by Application, 2023-2033
8.2.4.3. Market size analysis, by End User, 2023-2033
8.2.5. Italy
8.2.5.1. Market size analysis, by Product, 2023-2033
8.2.5.2. Market size analysis, by Application, 2023-2033
8.2.5.3. Market size analysis, by End User, 2023-2033
8.2.6. Rest of Europe
8.2.6.1. Market size analysis, by Product, 2023-2033
8.2.6.2. Market size analysis, by Application, 2023-2033
8.2.6.3. Market size analysis, by End User, 2023-2033
8.2.7. Research Dive Exclusive Insights
8.2.7.1. Market attractiveness
8.2.7.2. Competition heatmap
8.3. Asia-Pacific
8.3.1. China
8.3.1.1. Market size analysis, by Product, 2023-2033
8.3.1.2. Market size analysis, by Application, 2023-2033
8.3.1.3. Market size analysis, by End User, 2023-2033
8.3.2. Japan
8.3.2.1. Market size analysis, by Product, 2023-2033
8.3.2.2. Market size analysis, by Application, 2023-2033
8.3.2.3. Market size analysis, by End User, 2023-2033
8.3.3. India
8.3.3.1. Market size analysis, by Product, 2023-2033
8.3.3.2. Market size analysis, by Application, 2023-2033
8.3.3.3. Market size analysis, by End User, 2023-2033
8.3.4. Australia
8.3.4.1. Market size analysis, by Product, 2023-2033
8.3.4.2. Market size analysis, by Application, 2023-2033
8.3.4.3. Market size analysis, by End User, 2023-2033
8.3.5. South Korea
8.3.5.1. Market size analysis, by Product, 2023-2033
8.3.5.2. Market size analysis, by Application, 2023-2033
8.3.5.3. Market size analysis, by End User, 2023-2033
8.3.6. Rest of Asia-Pacific
8.3.6.1. Market size analysis, by Product, 2023-2033
8.3.6.2. Market size analysis, by Application, 2023-2033
8.3.6.3. Market size analysis, by End User, 2023-2033
8.3.7. Research Dive Exclusive Insights
8.3.7.1. Market attractiveness
8.3.7.2. Competition heatmap
8.4. LAMEA
8.4.1. Brazil
8.4.1.1. Market size analysis, by Product, 2023-2033
8.4.1.2. Market size analysis, by Application, 2023-2033
8.4.1.3. Market size analysis, by End User, 2023-2033
8.4.2. Saudi Arabia
8.4.2.1. Market size analysis, by Product, 2023-2033
8.4.2.2. Market size analysis, by Application, 2023-2033
8.4.2.3. Market size analysis, by End User, 2023-2033
8.4.3. UAE
8.4.3.1. Market size analysis, by Product, 2023-2033
8.4.3.2. Market size analysis, by Application, 2023-2033
8.4.3.3. Market size analysis, by End User, 2023-2033
8.4.4. South Africa
8.4.4.1. Market size analysis, by Product, 2023-2033
8.4.4.2. Market size analysis, by Application, 2023-2033
8.4.4.3. Market size analysis, by End User, 2023-2033
8.4.5. Rest of LAMEA
8.4.5.1. Market size analysis, by Product, 2023-2033
8.4.5.2. Market size analysis, by Application, 2023-2033
8.4.5.3. Market size analysis, by End User, 2023-2033
8.4.6. Research Dive Exclusive Insights
8.4.6.1. Market attractiveness
8.4.6.2. Competition heatmap
9. Competitive Landscape
9.1. Top winning strategies, 2022
9.1.1. By strategy
9.1.2. By year
9.2. Strategic overview
9.3. Market share analysis, 2023
10. Company Profiles
10.1. Medtronic
10.1.1. Overview
10.1.2. Business segments
10.1.3. Product portfolio
10.1.4. Financial performance
10.1.5. Recent developments
10.1.6. SWOT analysis
10.2. Becton Dickinson (BD)
10.2.1. Overview
10.2.2. Business segments
10.2.3. Product portfolio
10.2.4. Financial performance
10.2.5. Recent developments
10.2.6. SWOT analysis
10.3. Edward Lifesciences
10.3.1. Overview
10.3.2. Business segments
10.3.3. Product portfolio
10.3.4. Financial performance
10.3.5. Recent developments
10.3.6. SWOT analysis
10.4. LivaNova
10.4.1. Overview
10.4.2. Business segments
10.4.3. Product portfolio
10.4.4. Financial performance
10.4.5. Recent developments
10.4.6. SWOT analysis
10.5. Smiths Medical
10.5.1. Overview
10.5.2. Business segments
10.5.3. Product portfolio
10.5.4. Financial performance
10.5.5. Recent developments
10.5.6. SWOT analysis
10.6. Boston Scientific Corporation
10.6.1. Overview
10.6.2. Business segments
10.6.3. Product portfolio
10.6.4. Financial performance
10.6.5. Recent developments
10.6.6. SWOT analysis
10.7. Terumo Corporation
10.7.1. Overview
10.7.2. Business segments
10.7.3. Product portfolio
10.7.4. Financial performance
10.7.5. Recent developments
10.7.6. SWOT analysis
10.8. Fisher & Paykel Healthcare Ltd
10.8.1. Overview
10.8.2. Business segments
10.8.3. Product portfolio
10.8.4. Financial performance
10.8.5. Recent developments
10.8.6. SWOT analysis
10.9. Flexicare Medical
10.9.1. Overview
10.9.2. Business segments
10.9.3. Product portfolio
10.9.4. Financial performance
10.9.5. Recent developments
10.9.6. SWOT analysis
10.10. Medin Medical Innovations
10.10.1. Overview
10.10.2. Business segments
10.10.3. Product portfolio
10.10.4. Financial performance
10.10.5. Recent developments
10.10.6. SWOT analysis
* Taxes/Fees, If applicable will be added during checkout. All prices in USD.
Have a question ?
Enquire To BuyNeed to add more ?
Request Customization